How to Reconstitute CJC-1295 + GHRP-6 Blend: Step-by-Step Lab Guide
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
How to Reconstitute CJC-1295 + GHRP-6 Blend: Step-by-Step Lab Guide
The CJC-1295 + GHRP-6 Blend (2mg/2mg per vial) contains CJC-1295 No DAC (GHRH-R agonist) and GHRP-6 (GHSR-1a agonist) co-lyophilised in a single 10mL sterile glass vial. This blend provides simultaneous upstream GHRH-R and GHSR-1a receptor pathway activation in a single compound preparation, supporting dual-target GH axis research in pituitary somatotroph and GH axis cell model systems.
Materials Required
- CJC-1295 + GHRP-6 Blend 2mg/2mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe work surface with 70% isopropyl alcohol. Allow to dry. Wear nitrile gloves.
Step 2 — Swab both stoppers. Clean rubber stoppers on both vials with fresh alcohol swabs. Air dry 10 seconds each.
Step 3 — Draw 2mL BAC water. Draw 2mL of bacteriostatic water into a sterile syringe.
Step 4 — Inject along the vial wall. Direct BAC water slowly down the inner glass wall of the blend vial over 15 seconds.
Step 5 — Dissolve gently. Swirl for 20–30 seconds. Both peptides dissolve readily — the solution should be clear and colourless. Do not shake.
Step 6 — Label. Record date, concentrations (1mg/mL each), and initials.
Resulting Concentration
Adding 2mL BAC water to the 2mg/2mg blend vial yields 1mg/mL CJC-1295 No DAC + 1mg/mL GHRP-6 (1000mcg/mL each). For GH axis cell model assays, working concentrations of 1nM–100nM each are prepared by serial dilution into assay buffer or serum-free media.
Concentration Reference Table
| BAC Water Added | CJC-1295 No DAC | GHRP-6 |
|---|---|---|
| 1mL | 2.0mg/mL | 2.0mg/mL |
| 2mL | 1.0mg/mL | 1.0mg/mL |
Storage Conditions and Stability
Store lyophilised blend at −20°C prior to reconstitution. Once reconstituted, store at 2–8°C for up to 28 days. Do not freeze reconstituted solution. Prepare single-use aliquots for −80°C long-term storage.
Comparative GH Axis Research Applications
The CJC-1295 + GHRP-6 blend is particularly useful in comparative GH axis pharmacology studies where the researcher wants to evaluate GHRH-R/GHSR-1a synergy with a first-generation GHRP (GHRP-6) versus a second-generation GHRP (GHRP-2 in the CJC-1295+GHRP-2 blend). The dose-response curves for cAMP accumulation (GHRH-R mediated) are identical between the two blends at matched CJC-1295 concentrations, while the Gq/calcium component (GHSR-1a mediated) will show a rightward shift for GHRP-6 versus GHRP-2 due to GHRP-6's lower GHSR-1a binding affinity. These comparative data are valuable for establishing the contribution of GHSR-1a binding affinity to the overall synergistic GH secretion response in pituitary somatotroph cell models. Additionally, GHRP-6's known stimulation of ghrelin-associated hunger signalling pathways — absent with GHRP-2 and ipamorelin — provides a mechanistic distinction useful for studies examining non-GH endpoints of GHSR-1a activation in hypothalamic and enteric neuronal cell model systems.
Troubleshooting Common Reconstitution Issues
Powder not dissolving: Gently tilt and swirl to bring undissolved powder into contact with solvent. Do not heat. If incomplete after 60 seconds, inspect for moisture ingress or compromised seal.
Cloudy solution: Cloudiness may indicate aggregation or contamination. Discard if cloudiness persists after gentle swirling.
Foaming: Allow to settle naturally. Reduce injection speed on subsequent attempts and ensure stream is directed along the glass wall.
Loss of material: Swirl to contact all inner surfaces. Invert and draw from the stopper end for maximum recovery.
Research Application Notes
CJC-1295 + GHRP-6 provides complementary GH axis receptor co-activation via GHRH-R (Gs-cAMP) and GHSR-1a (Gq-calcium) pathways. GHRP-6 has lower GHSR-1a binding affinity than GHRP-2 but equivalent maximal efficacy — the CJC-1295 + GHRP-6 blend thus provides a lower-potency GHSR-1a component than the CJC-1295 + GHRP-2 blend, which is useful for generating right-shift comparison data on synergistic GH secretion profiles. Always run individual compound controls alongside blend studies to quantify synergistic versus additive GH axis activation responses in GH3 pituitary cell model preparations. CJC-1295 + GHRP-6 Blend 2mg/2mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
